Our data suggest that a few microRNAs may potentially regulate multiple key pathogenetically relevant pathways and processes, including fibrosis, hypertrophy, myocarditis and arrhythmia, IFNγ- and Nrf2-modulated and mitochondrial genes. The gene discussed is NFE2L2; the disease is myocarditis.